The Center for Cancer and Blood Disorders-Cleburne — Cleburne, Texas

The Center for Cancer and Blood Disorders-Cleburne is a clinical research site located in Cleburne, Texas, United States 76033.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

The Center for Cancer and Blood Disorders-Cleburne has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7.

Sponsors: National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cleburne

Browse all research sites in Texas · View every site in Cleburne

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Center for Cancer and Blood Disorders-Cleburne?

The Center for Cancer and Blood Disorders-Cleburne has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Center for Cancer and Blood Disorders-Cleburne conducted?

The Center for Cancer and Blood Disorders-Cleburne has 2 clinical trials on record, with 1 currently active. Their work covers Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7.

Is The Center for Cancer and Blood Disorders-Cleburne accredited by Crixeo Clinical Trials?

The Center for Cancer and Blood Disorders-Cleburne has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Center for Cancer and Blood Disorders-Cleburne?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.